Cargando…

The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes

Prescribing safe and effective medications is a challenge in psychiatry. While clinical use of pharmacogenomic testing for individual genes has provided some clinical benefit, it has largely failed to show clinical utility. However, pharmacogenomic testing that integrates relevant genetic variation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benitez, Joachim, Jablonski, Michael R., Allen, Josiah D., Winner, Joel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745398/ https://www.ncbi.nlm.nih.gov/pubmed/26937360 http://dx.doi.org/10.1016/j.atg.2015.03.001

Ejemplares similares

Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility
por: Winner, Joel G., et al.
Publicado: (2015)

Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
por: Fields, Eve S, et al.
Publicado: (2016)

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
por: Winner, J, et al.
Publicado: (2013)

Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy
por: Zhang, Lusi, et al.
Publicado: (2023)

Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)
por: Allen, Josiah D., et al.
Publicado: (2022)

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
por: Tiwari, Arun K., et al.
Publicado: (2022)

Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
por: Tiwari, Arun K., et al.
Publicado: (2022)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Clinical utility of pharmacogenomics in the management of hepatitis C
por: Trinks, Julieta, et al.
Publicado: (2014)

Using a pharmacogenomic algorithm to guide the treatment of depression
por: Hall-Flavin, D K, et al.
Publicado: (2012)

Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
por: Tanner, Julie-Anne, et al.
Publicado: (2019)

Intersection and Considerations for Patient-Centered Care, Patient Experience, and Medication Experience in Pharmacogenomics
por: Murry, Logan T., et al.
Publicado: (2023)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
por: Roman, Youssef M
Publicado: (2021)

Preliminary Clinical Investigation of Combinatorial Pharmacogenomic Testing for the Optimized Treatment of Depression: A Randomized Single-Blind Study
por: Shan, Xiaoxiao, et al.
Publicado: (2019)

A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling
por: Allen, Josiah D., et al.
Publicado: (2022)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
por: Arbitrio, Mariamena, et al.
Publicado: (2020)

1316. Clinical Utility of Pharmacogenomic Testing in Refractory Coccidioidal Meningitis
por: Blair, Janis E, et al.
Publicado: (2023)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
por: Takahashi, Paul Y, et al.
Publicado: (2021)

Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
por: Minelli, Alessandra, et al.
Publicado: (2021)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Leveraging the utility of pharmacogenomics in psychiatry through clinical decision support: a focus group study
por: Goodspeed, Andrew, et al.
Publicado: (2019)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
por: Pearce, Angela, et al.
Publicado: (2022)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2017)

Implementation of Pharmacogenomic Clinical Decision Support for Health Systems: A Cost-Utility Analysis
por: Jiang, Shangqing, et al.
Publicado: (2022)

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Pharmacogenomics in clinical trials: an overview
por: Nogueiras-Álvarez, Rita
Publicado: (2023)

Impact of Pharmacogenomics in Clinical Practice
por: Principi, Nicola, et al.
Publicado: (2023)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
por: Van Heukelom, Joel, et al.
Publicado: (2023)

Utilizing yeast chemogenomic profiles for the prediction of pharmacogenomic associations in humans
por: Silberberg, Yael, et al.
Publicado: (2016)

Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies
por: Rao, J. Sunil, et al.
Publicado: (2017)

Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
por: Mroz, Pawel, et al.
Publicado: (2021)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

PharmaKU: A Web-Based Tool Aimed at Improving Outreach and Clinical Utility of Pharmacogenomics
por: John, Sumi Elsa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkg4i41nl6ilo2cte96vg8dfsf